Edwards Lifesciences LLC, a Delaware limited liability company, and Edwards Lifesciences Corporation, a Delaware corporation v. Michael Thompson, an individual

CourtDistrict Court, D. Colorado
DecidedMarch 31, 2026
Docket1:24-cv-02558
StatusUnknown

This text of Edwards Lifesciences LLC, a Delaware limited liability company, and Edwards Lifesciences Corporation, a Delaware corporation v. Michael Thompson, an individual (Edwards Lifesciences LLC, a Delaware limited liability company, and Edwards Lifesciences Corporation, a Delaware corporation v. Michael Thompson, an individual) is published on Counsel Stack Legal Research, covering District Court, D. Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Edwards Lifesciences LLC, a Delaware limited liability company, and Edwards Lifesciences Corporation, a Delaware corporation v. Michael Thompson, an individual, (D. Colo. 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Judge Regina M. Rodriguez

Civil Action No. 24-cv-02558-RMR-KAS

EDWARDS LIFESCIENCES LLC, a Delaware limited liability company, and EDWARDS LIFESCIENCES CORPORATION, a Delaware corporation,

Plaintiffs,

v.

MICHAEL THOMPSON, an individual,

Defendant.

ORDER

This matter is before the Court on the Recommendation of United States Magistrate Judge Kathryn A. Starnella, ECF No. 196, entered February 27, 2026, addressing Defendant Abbott Laboratories’ Motion to Dismiss Pursuant to Fed. R. Civ. P. 12(B)(2) and 12(B)(6) (“Abbott’s Motion”), ECF No. 112, and Plaintiffs’ Motion to Dismiss Thompson’s Counterclaims (“Plaintiffs' Motion”), ECF No. 138. Magistrate Judge Starnella recommends that Abbott’s Motion be granted in part and denied in part and that Plaintiffs’ motion be granted. Defendants Thompson and Abbott jointly filed a timely Objection. ECF No. 197. Plaintiffs also filed a timely Objection. ECF No. 198. Both sides filed responses to the respective objections. ECF Nos. 199, 200. For the reasons stated below, the Court overrules the parties’ objections and adopts the Recommendation. I. BACKGROUND This is a trade secret misappropriation case. Plaintiffs Edward Sciences, LLC and Edward Sciences Corporation (collectively “Edwards” or “Plaintiffs”) sued and moved the Court for a Preliminary Injunction (“PI”), ECF No. 10, to stop its former employee, Defendant Michael Thompson (“Thompson”) from working or performing services for his new employer, Abbott Laboratories (“Abbott”). On June 18, 2025, this Court granted Plaintiffs' request for a preliminary injunction, ECF No. 107, which is pending appeal with the Tenth Circuit, ECF No. 116. The parties do not object to the factual or procedural background outlined in the

Recommendation. Accordingly, the Court adopts and incorporates the factual and procedural background included within the Recommendation as if set forth therein. Plaintiffs assert claims against both Abbott and Thompson under the Defend Trade Secrets Act (“DTSA”), 18 U.S.C. § 1832, et seq., and the Colorado Uniform Trade Secrets Act (“CUTSA”), Colo. Rev. Stat. § 7-74-101, et seq. ECF No. 102 ¶¶ 80-94. Solely against Thompson, Plaintiffs assert state law claims for breach of contract and breach of duty of loyalty. Id. ¶¶ 95-107. Solely against Abbott, Plaintiffs assert state law claims of tortious interference with Thompson’s contract and tortious interference with prospective business advantage regarding Plaintiffs’ customers. Id. ¶¶ 108-120. Thompson asserts two state-law counterclaims against Plaintiffs. Id. ¶¶ 49–63.

First, he asserts a claim under Colo. Rev. Stat. § 8-2-113, alleging that Plaintiffs’ attempt to enforce non-compete and non-solicitation provisions in his Employment Agreement is unlawful. Id. ¶¶ 49-53. Second, he asserts a claim for tortious interference with an employment relationship, alleging that Plaintiffs’ efforts to enforce the non-compete and non-solicitation provisions effectively prevent him from working for Abbott. Id. ¶¶ 54–63. II. LEGAL STANDARD This Court is required to make a de novo determination of the magistrate judge’s recommendation to which a specific objection has been made, and it may accept, reject, or modify any or all of the magistrate judge’s findings or recommendations. 28 U.S.C. § 636(b)(1) (“A judge of the court shall make a de novo determination of those portions of the report or specified proposed findings or recommendations to which objection is made.”); Fed. R. Civ. P. 72(b)(3) (“The district judge must determine de novo any part of

the magistrate judge’s disposition that has been properly objected to.”). “[A] party’s objections to the magistrate judge’s report and recommendation must be both timely and specific to preserve an issue for de novo review by the district court or for appellate review.” United States v. One Parcel of Real Property, 73 F.3d 1057, 1060 (10th Cir. 1996). III. ANALYSIS Defendants Abbott and Thompson raise two objections, one each, to the Recommendation. ECF No. 197. Plaintiffs raised one objection to the Recommendation. The Court will address Abbott’s objection first, then Thompson’s, and finally Plaintiffs’ objection.

A. Abbott’s Objection Abbott objects to Magistrate Judge Starnella’s findings that this Court may exercise specific personal jurisdiction over Abbott. ECF No. 197 at 2. Specifically, Abbott objects to a finding that it purposefully availed itself to Colorado, or in other words, that it “deliberately . . . engaged in significant activities within’ the forum State [Colorado] or deliberately directed its activities at the forum State [Colorado], so that it has ‘manifestly availed [itself] of the privilege of conducting business there” or that “[Plaintiffs’] claims arise out of or relate to [Abbott’s] forum conduct.” XMission, L.C. v. PureHealth Rsch., 105 F.4th 1300, 1308, 1312 (10th Cir. 2024) (quotation and citations omitted). Abbott argues that Magistrate Judge Starnella’s reliance on an out-of-Circuit case, Vessel Medical, Inc. v. Elliott, No. 6:15-cv-00330-MGL, 2015 WL 5437170, at *5-6 (S.D.S.C. Sept 15, 2015), was erroneous. Specifically, Abbott argues that “Thompson

cannot have been ‘acting as [Abbott’s] agent when he act[ed] outside the scope of employment.” ECF No. 197 at 3 (quoting United States v. Smith, 810 F.2d 996, 997 (10th Cir. 1987)).1 Abbott has not provided any case law to suggest that Magistrate Judge Starnella cannot find an out-of-Circuit case with analogous facts persuasive. The Court would not go so far as to say Magistrate Judge Starnella found that Thompson was working as Abbott’s agent in Colorado before he started working for Abbott. See ECF No. 196 at 18 (“[T]hrough Thompson, Abbott engaged in intentional acts in Colorado with the aim of cutting into Plaintiffs’ market share” (emphasis added)). The Court finds that Abbott Vice President Chris Waddell (“Waddell”), not Thompson, was acting as Abbott's agent in Colorado. The focus should be on Waddell's

conduct directed at the form state. In November 2023, Waddell contacted Thompson, a Colorado resident, regarding a potential sales position for TAVI, Abbott’s version of

1 Smith is a criminal drug case and has no bearing on personal jurisdiction. Plaintiffs' product, TAVR. ECF No. 102 ¶ 45. Waddell knew that Thompson worked for Plaintiffs and likely had contractual obligations with Plaintiffs. Waddell also knew that Thompson worked in multiple states, including Colorado, and that he had access to Plaintiffs’ trade secrets that would be of value to Abbott. In May 2024, Waddell informed Thompson that Abbott might have a Regional Sales Director (“RSD”) position available. Id. ¶ 26. On July 3, 2024, Thompson and Waddell discussed a strategy for Abbott to expand into the Kansas and Nebraska markets, including Thompson providing site recommendations, contact information, and follow-up calls. Id. ¶¶ 47-50. On July 9, 2024, after a phone call with Waddell, Thompson texted him “Sites to consider:” and listed

several Colorado hospitals and key implanters at those facilities. ECF No. 132-10 at 2.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Geoffrey B. Smith, Jr.
810 F.2d 996 (Tenth Circuit, 1987)
AST Sports Science, Inc. v. CLF Distribution Ltd.
514 F.3d 1054 (Tenth Circuit, 2008)
Harris Group, Inc. v. Robinson
209 P.3d 1188 (Colorado Court of Appeals, 2009)
Dental Dynamics v. Jolly Dental Group
946 F.3d 1223 (Tenth Circuit, 2020)
United States v. 2121 East 30th Street
73 F.3d 1057 (Tenth Circuit, 1996)
XMission, LC v. PureHealth Research
105 F.4th 1300 (Tenth Circuit, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
Edwards Lifesciences LLC, a Delaware limited liability company, and Edwards Lifesciences Corporation, a Delaware corporation v. Michael Thompson, an individual, Counsel Stack Legal Research, https://law.counselstack.com/opinion/edwards-lifesciences-llc-a-delaware-limited-liability-company-and-edwards-cod-2026.